This user has not added any information to their profile yet.
Dr Mohamed Zahir Alimohamed is a Tanzanian molecular geneticist, lecturer, researcher and genetic counsellor at the Muhimbili University of Health and Allied Sciences (MUHAS). He holds a PhD in Medical Genetics from the University Medical Center Groningen, the Netherlands, an MSc in Molecular Biology and Biotechnology from the University of Groningen, and a BSc in Biotechnology from Manipal University. He is also a co-founder and Secretary General of the Tanzania Human Genetics Organization (THGO) and serves in regional and international initiatives advancing human genetics, genomics and precision medicine in Africa.
His research focuses on human genetics and genomics, precision medicine, inherited cardiovascular diseases, cancer genetics, pharmacogenomics, sickle cell disease and rare diseases. His work particularly addresses the translation of genomic technologies into healthcare systems in African settings, including genetic counselling, genomic diagnostics, implementation science, capacity building and equitable access to precision medicine.
Dr Alimohamed is involved in several research and capacity-building initiatives in Tanzania and across Africa. His current work includes establishing genomic approaches for inherited cardiomyopathies, strengthening hereditary breast cancer and BRCA1/BRCA2 testing, advancing sickle cell genomic and advanced-therapy research, and supporting initiatives in rare diseases, pharmacogenomics and genomic medicine implementation. He is also actively involved in developing national and regional capacity for genetics and genomics through training, policy engagement, research collaborations and professional networks.
Alimohamed MZ, El-Kamah G, Hamdi Y, Vicente-Crespo M, Ndiaye R, Ramsay M. Advancing global genomic equity: making a case for national genome projects in Africa. Nat Commun. 2026 Jun 24;17(1):5572. doi: 10.1038/s41467-026-74952-7. PMID: 42342701; PMCID: PMC13294329.
Hernandez HW, Epstein HM, Alimohamed MZ, Haskell H, Mentis AF, Pearce DA, Kanter M. Diagnostic uncertainty as a public health imperative: a call for R69 code adoption. Diagnosis (Berl). 2026 Apr 23. doi: 10.1515/dx-2026-0049. Epub ahead of print. PMID: 42043777.
Marandu TF, Sudi L, Mbwele B, Kiula A, Alimohamed MZ, Sylvester P, Msangi S, Mgaya R, Olomi W, Ngowi B, Ngatunga C, Mwakyula IH, Chachage M. Long-term immune profiling of COVID-19 recovered patients: effects of disease severity and vaccination. Front Immunol. 2026 Apr 10;17:1699992. doi: 10.3389/fimmu.2026.1699992. PMID: 42039170; PMCID: PMC13106164.
Alimohamed MZ, Kiula A, Fundikira L, Letara N, Mayala H, Sijmons R, Jongbloed JDH, Hershberger RE, Williams SM, Asselbergs FW, Chillo P. Systemic barriers and opportunities for equity in early implementation of genetic testing and counseling for cardiomyopathies in Tanzania. Commun Med (Lond). 2025 Nov 15;6(1):3. doi: 10.1038/s43856-025-01244-4. PMID: 41258130; PMCID: PMC12764781.
Alimohamed MZ, Obeng GD, Csanadi M, Masimirembwa C, Dandara C. Implementing health economics for pharmacogenomics research translation in Africa. Commun Med (Lond). 2025 Jun 20;5(1):241. doi: 10.1038/s43856-025-00955-y. PMID: 40542221; PMCID: PMC12181413.
